Edition:
United States

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.28USD
3:59pm EST
Change (% chg)

$-0.01 (-3.91%)
Prev Close
$0.29
Open
$0.29
Day's High
$0.29
Day's Low
$0.27
Volume
113,693
Avg. Vol
249,757
52-wk High
$2.75
52-wk Low
$0.26

Select another date:

Fri, Jan 26 2018

BRIEF-Biocept Prices $15 Million Public Offering Of 33.3 Mln Shares and Warrants

* BIOCEPT ANNOUNCES PRICING OF $15.0 MILLION PUBLIC OFFERING OF 33,333,333 SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE 33,333,333 SHARES OF COMMON STOCK

BRIEF-Biocept Offers 18.8 Mln Shares Of Common Stock

* BIOCEPT INC FILES TO SAY IT OFFERING 18.8 MILLION SHARES OF ITS COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF COMMON STOCK - SEC FILING

BRIEF-Biocept Inc Says Signed An In-Network Provider Agreement With Wellmark Inc

* BIOCEPT INC - HAS SIGNED AN IN-NETWORK PROVIDER AGREEMENT WITH WELLMARK INC Source text for Eikon: Further company coverage:

BRIEF-Sabby Management LLC Reports A 9.20 Pct Passive Stake In Biocept

* SABBY MANAGEMENT LLC REPORTS A 9.20 PCT PASSIVE STAKE IN BIOCEPT INC AS OF DEC 5 - SEC FILING Source text: (http://bit.ly/2ACbgue) Further company coverage:

BRIEF-Biocept announces pricing of public offering of up to 4,925,936 shares of common stock

* BIOCEPT ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 4,925,936 SHARES OF COMMON STOCK

BRIEF-Biocept And UC San Diego Medical Center Announce Clinical Study Collaboration To Demonstrate Utility Of Biocept's Liquid Biopsy Test In Immunotherapy

* BIOCEPT AND UC SAN DIEGO MEDICAL CENTER ANNOUNCE CLINICAL STUDY COLLABORATION TO DEMONSTRATE UTILITY OF BIOCEPT'S LIQUID BIOPSY TEST IN IMMUNOTHERAPY Source text for Eikon: Further company coverage:

BRIEF-Biocept files for offering $10 mln of shares of co's common stock and warrants

* Biocept Inc files for offering $10 million of shares of co's common stock and warrants - SEC Filing

BRIEF-Biocept reports Q3 loss per share $0.20

* Biocept Inc - ‍cash and cash equivalents were $5.9 million as of September 30, 2017​ Source text for Eikon: Further company coverage:

BRIEF-Biocept and Miraca Life Sciences enter into marketing agreement

* Biocept and Miraca Life Sciences enter into marketing agreement to expand target selector testing in the United States

Select another date: